Ubs Oconnor LLC Cytom X Therapeutics, Inc. Transaction History

Ubs Oconnor LLC

  • $1.46 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$1.41 - $1.92 $366,550 - $499,132
259,965 New
259,965 $447 Million
Q1 2023

May 15, 2023
BUY
$1.48 - $2.88 $76,618 - $149,094
51,769 Added 26.5%
247,157 $373,000
Q4 2022

Feb 14, 2023
BUY
$1.19 - $1.91 $232,511 - $373,191
195,388 New
195,388 $0

Others Institutions Holding CTMX

# of Institutions
72
Shares Held
49.4M
Call Options Held
112K
Put Options Held
8.3K
View Full List

About CytomX Therapeutics, Inc.

CTMX Quotes by TradingView
  • Ticker CTMX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,950,200
  • Market Cap $55.4M
  • Description
  • CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...
More about CTMX
Track This Portfolio

Track Ubs Oconnor LLC Portfolio

Follow Ubs Oconnor LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Oconnor LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email